Camurus to present at the Jefferies 2018 Global Healthcare Conference
Lund — 25 May 2018 — Camurus AB (Nasdaq Stockholm; CAMX) today announced that the Company will present at the Jefferies 2018 Healthcare Conference in New York on Tuesday 5 June at 8:30 am local time (EDT). Fredrik Tiberg PhD, President and Chief Executive Officer, will update on the progress on the development pipeline, including the ongoing registration processes of the company’s weekly and monthly buprenorphine depots (CAM2038) under development for treatment of opioid dependence. A webcast of the presentation can be accessed live via Camurus’ website www.camurus.com/investors or at